International Study on Fertility Preservation in Young Women Undergoing Cancer Treatment Comparing Fertility and Cancer Outcomes with Standard Treatments

What this Trial Is About

This research focuses on young women with cancer who are receiving fertility preserving cancer treatments. The study aims to track how often these treatments are used, the types of treatments given, and the long-term outcomes related to both cancer and fertility. It compares results from women receiving fertility sparing treatments to those undergoing standard cancer treatments. The study is an international, multicenter prospective observational trial designed to improve understanding of the safety and effectiveness of fertility preservation in cancer care. Participants in this study are young women with cancer who choose fertility preserving treatments during their cancer care. These treatments may vary across centers and deviate from standard protocols to protect fertility while treating cancer. The study records detailed information about cancer diagnosis, treatment methods, and both oncological and fertility outcomes over time. All patients receive fertility sparing cancer treatment based on their specific request. During the study, researchers collect data on cancer diagnosis, treatment, and outcomes, focusing on both cancer control and fertility preservation. The primary outcome measured is fertility outcome over 10 years, while oncological outcomes are tracked over 5 years. Participants provide written consent, and the study follows them long term to understand the effects of fertility preserving cancer treatments on survival and reproductive health. The total participation duration spans multiple years for ongoing follow-up.

Fertility Preservation in Young Women With Cancer